Only GILENYA® combines proven efficacy to cut multiple sclerosis (MS) relapses in half vs a leading injectable, in a once-daily* pill. Studies showed that GILENYA reduced the frequency of relapses by 52% in a 1-year study vs interferon beta-1a IM, and 54% in a 2-year study vs placebo.
For many people, reducing the number of relapses and slowing down the physical problems MS causes are both important considerations when thinking about a treatment for relapsing forms of MS.
Today, you have a chance to take a stance against relapsing MS....GILENYA might help in doing just that.
*GILENYA can result in a slow heart rate when first taken. Your first dose will be given in a medical facility where you will be watched for at least 6 hours. If you stop taking GILENYA for more than 14 days after your first month of treatment, you will need to repeat this observation.
†The mechanism of how GILENYA works in MS is unknown.